1616629-00-5

Downstream Products

• 1616628-82-0 5-{(5-[4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzoylamino]-2-methylbenzyl)amino}-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid methylamide 
• 1616689-30-5 5-{(5-[4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzoylamino]-2-methylphenoxy)methyl}-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid methyl ester 
• 1616689-14-5 5-(2-{5-[4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzoylamino]-2-methylphenyl}ethyl)-1H-pyrrolo[2,3-b]pyridine-2-carboxylic acid methyl ester 
• 1616628-81-9 N-{3-[((2-acetyl-1H-pyrrolo[2,3-b]pyridin-5-yl)amino)methyl]-4-methylphenyl}-4-((3-(dimethylamino)pyrrolidin-1-yl)methyl)-3-(trifluoromethyl)benzamide 
• 1240322-48-8 ND₀₁₁₉ 

Relevant academic research and scientific papers

NOVEL IMIDAZOPYRIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME AS ACTIVE INGREDIENT FOR PREVENTING OR TREATING CANCER

The present invention relates to a novel imidazopyridine derivative, a method for preparing the same, and a pharmaceutical composition containing the same as an active ingredient for preventing or treating cancer. The novel imidazopyridine derivative acco

PROTEIN KINASE INHIBITORS

The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.

AZAINDOLE DERIVATIVES AS MULTI KINASE INHIBITORS

The present invention relates to compounds of the following formula (I) and/or the pharmaceutically acceptable addition salts, solvates, enantiomers, diastereoisomers thereof, as well as mixtures thereof. The subject matter of the present invention thus also includes the preparation of compounds of formula (I), their uses, in particular in the inhibition of protein kinases which are implicated for example in numerous diseases such as cancers or immune system disorders.